Pallas Capital Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$609K Buy
2,901
+1,817
+168% +$457K 0.02% 452
2025
Q4
$308K Sell
1,084
-4
-0.4% -$1.25K 0.01% 671
2025
Q3
$336K Buy
1,088
+9
+0.8% +$2.82K 0.01% 640
2025
Q2
$339K Sell
1,079
-1
-0.1% -$289 0.01% 611
2025
Q1
$284K Buy
1,080
+7
+0.7% +$1.89K 0.01% 602
2024
Q4
$280K Buy
1,073
+2
+0.2% +$504 0.01% 482
2024
Q3
$255K Sell
1,071
-22
-2% -$4.52K 0.01% 514
2024
Q2
$213K Buy
+1,093
New +$197K 0.01% 478

Other funds holding PODD

Pallas Capital Advisors's PODD Position: Q1 2026 in Review

Pallas Capital Advisors increased its Insulet (PODD) stake by 168% in Q1 2026, buying an estimated $457K and bringing the position to 2,901 shares worth $609K. The position accounts for 0.02% of the portfolio, ranked #452.

Pallas Capital Advisors first reported a position in PODD in Q2 2024 and has held it in 8 quarters since. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Pallas Capital Advisors held 2,901 shares of Insulet worth $609K as of Q1 2026.
  • Pallas Capital Advisors bought 1,817 Insulet shares in Q1 2026, an estimated $457K.
  • Insulet made up 0.02% of Pallas Capital Advisors's portfolio in Q1 2026, its #452 holding.
  • Pallas Capital Advisors first reported a position in Insulet in Q2 2024 and has held it in 8 quarters since.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.